| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |